Related Experiment Video

Updated: May 4, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Combinations of TLR ligands: a promising approach in cancer immunotherapy

Saskia Stier1, Claudia Maletzki1, Ulrike Klier1

  • 1Department of General Surgery, Molecular Oncology and Immunotherapy, University of Rostock, Schillingallee 35, 18057 Rostock, Germany.

Clinical & Developmental Immunology
|December 28, 2013
PubMed

Insights

Toll-like receptors (TLRs) show dual roles in colorectal cancer. While Taxol effectively inhibited tumor growth, combinations with other TLR ligands yielded varied results, highlighting the need for careful selection in cancer therapy.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Toll-like receptors (TLRs) are key pattern recognition receptors typically on immune cells.
  • Emerging evidence shows functional TLRs on tumor cells, with both pro-tumor and anti-tumor effects.
  • The precise role of TLRs in colorectal cancer (CRC) requires further elucidation.

Purpose of the Study:

  • To investigate the impact of TLR ligands on colorectal cancer cell lines.
  • To evaluate the efficacy of TLR ligands, including Taxol, alone and in combination.
  • To assess the combined effects of TLR ligands and human lymphocytes on tumor growth.

Main Methods:

  • In vitro testing of TLR ligands (LPS, Poly I:C, R848, Taxol) on human CRC cell lines (HROC40, HROC60, HROC69).
  • In vivo studies using CT26 tumor model.
  • Assessment of tumor cell viability, apoptosis, and tumor growth control.

Main Results:

  • Taxol demonstrated significant inhibition of CRC cell growth and viability.
  • Other TLR ligands (R848, LPS, Poly I:C) showed marginal effects individually.
  • Combinations with lymphocytes boosted anti-tumoral effects; specific ligand combinations showed varied outcomes in vivo, with Taxol + R848 being most effective and Taxol + LPS accelerating growth.

Conclusions:

  • TLR ligands possess potential for controlling tumor growth and activating immune responses in CRC.
  • The efficacy of TLR-targeted therapies is highly dependent on the specific ligand combinations used.
  • Strategic selection of TLR ligands and combination therapies is crucial for optimizing anti-cancer outcomes.

More Related Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

1.8K
Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling09:51

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling

Published on: July 26, 2017

11.9K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K